Highlights
NASDAQ: IMMP       Immutep Ltd ADR
Last Price Today's Change   Day's Range   Trading Volume
1.66   -0.04 (2.35%)  1.62 - 1.739  16,400

Overview

 
Avg Volume (4 weeks):22,414
4 Weeks Range:1.62 - 1.95
4 Weeks Price Volatility (%):
12.12%
52 Weeks Range:1.27 - 3.23
52 Weeks Price Volatility (%):
19.90%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Prima BioMed Ltd is a globally active biotechnology company developing immunotherapeutic products for cancer and autoimmune diseases. Its lead product is IMP321, which involves in clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trails, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia and derives most of the revenue from the sale of the products.

  Be the first to like this.
 


 

4706  3347  638  230 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 GDX 26.97-0.65 
 CHK 0.76+0.041 
 EEM 43.07+0.25 
 BAC 33.67+0.58 
 GE 11.10+0.31 
 SPY 314.87+2.85 
 XOP 21.23+0.74 
 VIAB 24.22+0.75 
 ONTX 0.35+0.058 
Partners & Brokers